HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Characterization of chronic lymphocytic leukemia (CLL) cells with low density of surface membrane bound immunoglobulins (smIg).

Abstract
The study consists of 6 CLL patients with leukemic blood lymphocytes lacking T-cell characteristics and with smIg on only a very small fraction of the cells detected by microscopy or FACS analysis after direct immunofluorescence (IFL) staining. Using B-cell specific monoclonal antibodies all leukemias were found to be of the B-cell type. SmIg, mainly of IgD-class and the monotypic light chain, was detected on a large number of cells in all cases when using direct IFL. No lymphocyte clone was judged to be of the pre-B-cell type or represented fully differentiated terminal B-cells. CLL cells from the individual cases probably represent intermediate B-cell maturation steps. The results lend no support to the suggestion that this subtype of CLL necessarily belongs to an early stage of differentiation just beyond the pre-B-cell level.
AuthorsE Kimby, B Axelsson, M Björkholm, J Gordon, G Holm, H Mellstedt
JournalMedical oncology and tumor pharmacotherapy (Med Oncol Tumor Pharmacother) Vol. 2 Issue 4 Pg. 261-7 ( 1985) ISSN: 0736-0118 [Print] England
PMID2935687 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antibodies, Monoclonal
  • Antigens, Differentiation, T-Lymphocyte
  • Antigens, Neoplasm
  • Antigens, Surface
  • Immunoglobulin Light Chains
  • Receptors, Antigen, B-Cell
  • Neprilysin
  • Tetradecanoylphorbol Acetate
Topics
  • Antibodies, Monoclonal
  • Antigens, Differentiation, T-Lymphocyte
  • Antigens, Neoplasm (analysis)
  • Antigens, Surface (analysis)
  • B-Lymphocytes (immunology)
  • Cell Differentiation
  • Flow Cytometry
  • Fluorescent Antibody Technique
  • Humans
  • Immunoglobulin Light Chains (analysis, biosynthesis)
  • Leukemia, Lymphoid (immunology)
  • Neprilysin
  • Receptors, Antigen, B-Cell (analysis)
  • Tetradecanoylphorbol Acetate (pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: